thebench.bio

Funding Daily Summary

Funding Daily Summary: What Happened on October 5, 2026

Fundraising advice centers on investor trust

BioBrokers founder Valeriia Simanovskaia argues that credibility and steady communication can help biotech companies reach investors.

  • Updated
  • Read from 1 article, 1 publication

Today in brief

Valeriia Simanovskaia says trusted introductions can help biotech companies get investor attention and raise capital.1

Why relationships matter in fundraising

A company’s scientific merits and commercial prospects may not be enough to secure investor attention, BioBrokers founder and CEO Valeriia Simanovskaia argues.1 She says trusted introductions can reduce uncertainty for investors more quickly than a presentation alone.1

Simanovskaia says a well-known investment organization asked her to present a company directly because it trusted her judgment and wanted her firsthand perspective.1 She argues that investor relationships grow through consistent communication, delivered milestones and honest handling of setbacks, not a single meeting.1

Simanovskaia advises life-sciences companies on fundraising and strategic transactions.1

Sources

  1. Source 1: European Biotechnology Fundraising: Why relationships matter more than ever https://european-biotechnology.com/opinion/fundraising-why-relationships-matter-more-than-ever/

The Bench wrote this from the reporting cited above, with a language model drafting and editing.